QLIFE Stock Overview
A med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Qlife Holding AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 2.48 |
| 52 Week High | SEK 179.00 |
| 52 Week Low | SEK 1.30 |
| Beta | 0.89 |
| 11 Month Change | -8.15% |
| 3 Month Change | 12.73% |
| 1 Year Change | -96.17% |
| 33 Year Change | -100.00% |
| 5 Year Change | n/a |
| Change since IPO | -99.99% |
Recent News & Updates
Shareholder Returns
| QLIFE | SE Medical Equipment | SE Market | |
|---|---|---|---|
| 7D | -0.8% | -3.2% | -0.1% |
| 1Y | -96.2% | 18.9% | 28.5% |
Return vs Industry: QLIFE underperformed the Swedish Medical Equipment industry which returned 18.9% over the past year.
Return vs Market: QLIFE underperformed the Swedish Market which returned 28.5% over the past year.
Price Volatility
| QLIFE volatility | |
|---|---|
| QLIFE Average Weekly Movement | 25.4% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 5.3% |
| 10% most volatile stocks in SE Market | 11.5% |
| 10% least volatile stocks in SE Market | 3.2% |
Stable Share Price: QLIFE's share price has been volatile over the past 3 months compared to the Swedish market.
Volatility Over Time: QLIFE's weekly volatility (25%) has been stable over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2019 | 7 | Thomas Warthoe | www.qlifeholding.com |
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents. The company offers Egoo Health Platform, an integrated platform with a measuring instrument with disposable capsules and software, where each capsule contains a test for a specific biomarker or virus.
Qlife Holding AB (publ) Fundamentals Summary
| QLIFE fundamental statistics | |
|---|---|
| Market cap | SEK 5.75m |
| Earnings (TTM) | -SEK 141.80m |
| Revenue (TTM) | SEK 114.00k |
50.4x
P/S Ratio0.0x
P/E RatioIs QLIFE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| QLIFE income statement (TTM) | |
|---|---|
| Revenue | SEK 114.00k |
| Cost of Revenue | SEK 4.02m |
| Gross Profit | -SEK 3.91m |
| Other Expenses | SEK 137.89m |
| Earnings | -SEK 141.80m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 07, 2024
| Earnings per share (EPS) | -61.16 |
| Gross Margin | -3,428.95% |
| Net Profit Margin | -124,387.72% |
| Debt/Equity Ratio | -11.5% |
How did QLIFE perform over the long term?
See historical performance and comparison